Cue Health accelerates growth with $235-million raise

Cue Health announced on Wednesday the closing of a $235-million private financing round to advance its efforts in digital healthcare, beginning with diagnostics. "The world needs to make the move to Healthcare 2.0, a decentralised, responsive, digital-first and consumer-centric model that makes it easy to access important health information and act on it," said CEO Ayub Khattak, adding "we believe distributed diagnostics is the key missing piece to bridge the physical to virtual care continuum."

Connecting diagnostics with telemedicine

According to Cue Health, its monitoring system is designed to deliver a broad menu of tests through one system. The company says it plans to develop products to address respiratory, sexual, cardiac, metabolic, women's and men's health, along with chronic disease management "by connecting diagnostics with telemedicine."

Last June, Cue Health raised $100 million in funding, with proceeds going toward completing development and manufacturing scale-up of its rapid molecular testing platform. The company's Cue COVID-19 test kit, which runs on the system, was later granted an emergency-use authorisation by the FDA.

To ensure you don't miss other Top Stories like these and news on key healthtech industry developments, sign up for our free daily e-newsletter here.  

Did you like this article?